Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca launches diabetes portal in Germany

Zuckerkrank.de is designed to educate patients and families
zuckerkrank_de_start_astrazeneca

AstraZeneca has launched a new online portal for patients and families to learn about living with type 2 diabetes.

Zuckerkrank.de has information on treatment options and outlines how type 2 diabetes patients can use exercise and diet to improve the likelihood of successful treatment.

Visitors to the site can download a nutrition guide, for example. This includes examples of food labelled according to the traffic light system.

Tips and practical advice for everyday life with type 2 diabetes are also available, as well as a range of materials and advice from experts. Other features of the portal include information on treatment options and individual treatment levels.

Topics covered include diabetes and mental health, and separate sections on the site outline diabetes-related events and links to other useful information sources.

Patients will also find information on diabetes care during pregnancy, and how best to maintain their blood sugar levels when travelling, for example.

Advice is also given on how to manage careers while coping with type 2 diabetes and its symptoms. The site explains, for instance, whether sufferers are obliged to disclose the condition when applying for jobs, and lists roles unsuited to people at risk from hypoglycaemia.

Type 2 diabetes is a priority area for AstraZeneca and the company's Diabetic Initiative in Germany aims to inform people about the disease while supporting those affected. The new portal is the first step in this awareness campaign.

19th August 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Precision medicine and the changing role of the healthcare professional
The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of...
How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma...
eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation
Hear what Anthill's delegates reported back from the biggest eyeforpharma Barcelona yet....

Infographics